These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8400629)

  • 21. Effects of prenatal exposure to the environmental pollutant 2-bromopropane on embryo-fetal development in rats.
    Kim JC; Kim SH; Shin DH; Ahn TH; Kim HC; Kim YB; Jiang CZ; Han J; Chung MK
    Toxicology; 2004 Mar; 196(1-2):77-86. PubMed ID: 15036758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Dutch-Belted rabbit: an alternative breed for developmental toxicity testing.
    Spence S
    Birth Defects Res B Dev Reprod Toxicol; 2003 Oct; 68(5):439-48. PubMed ID: 14745994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of structure-activity relationship (SAR) models for prediction and covariate selection in developmental toxicity: comparative analysis of logistic regression and decision tree models.
    Arena VC; Sussman NB; Mazumdar S; Yu S; Macina OT
    SAR QSAR Environ Res; 2004 Feb; 15(1):1-18. PubMed ID: 15113065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys.
    Neubert RT; Webb JR; Neubert D
    Hum Exp Toxicol; 2002; 21(9-10):543-67. PubMed ID: 12458914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introductory remarks: Session on developmental factors affecting pollutant toxicity.
    Fabro S
    Environ Health Perspect; 1979 Apr; 29():5-6. PubMed ID: 510242
    [No Abstract]   [Full Text] [Related]  

  • 26. The rat as a model in developmental immunotoxicology.
    Smialowicz RJ
    Hum Exp Toxicol; 2002; 21(9-10):513-9. PubMed ID: 12458909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zebrafish: as an integrative model for twenty-first century toxicity testing.
    Sipes NS; Padilla S; Knudsen TB
    Birth Defects Res C Embryo Today; 2011 Sep; 93(3):256-67. PubMed ID: 21932434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teratogenic potential of cocaine.
    Buehler BA; Conover B; Andres RL
    Semin Perinatol; 1996 Apr; 20(2):93-8. PubMed ID: 8857694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental effects of methylated arsenic metabolites in mice.
    Hood RD
    Bull Environ Contam Toxicol; 1998 Aug; 61(2):231-8. PubMed ID: 9702361
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro methodologies for enhanced toxicity testing.
    DelRaso NJ
    Toxicol Lett; 1993 May; 68(1-2):91-9. PubMed ID: 8516778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution and progress in safety assessment for developmental and reproductive toxicity.
    Kimmel CA; Schwetz BA
    Toxicol Pathol; 1997; 25(6):664-7. PubMed ID: 9437819
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Difficulties in identifying selective developmental toxicity.
    Johnson EM; Newman LM
    Fundam Appl Toxicol; 1992 May; 18(4):635-40. PubMed ID: 1526379
    [No Abstract]   [Full Text] [Related]  

  • 33. Current and future needs for developmental toxicity testing.
    Makris SL; Kim JH; Ellis A; Faber W; Harrouk W; Lewis JM; Paule MG; Seed J; Tassinari M; Tyl R
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):384-94. PubMed ID: 21922641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Issues in qualitative and quantitative risk analysis for developmental toxicology.
    Kimmel CA; Gaylor DW
    Risk Anal; 1988 Mar; 8(1):15-20. PubMed ID: 3375503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental toxicity evaluation of piperonyl butoxide in CD-1 mice.
    Tanaka T; Fujitani T; Takahashi O; Oishi S
    Toxicol Lett; 1994 Apr; 71(2):123-9. PubMed ID: 8171442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some remaining problems in the reproductive toxicity testing of drugs.
    Berry CL; Barlow S
    Br Med Bull; 1976 Jan; 32(1):34-8. PubMed ID: 816408
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of maternal and developmental toxicity. Proceedings of the consensus workshop. Rockville, Maryland, May 12-14, 1986.
    Teratog Carcinog Mutagen; 1987; 7(3):201-338. PubMed ID: 2888200
    [No Abstract]   [Full Text] [Related]  

  • 38. Developmental toxicity evaluation of gallium nitrate in mice.
    Gómez M; Sánchez DJ; Domingo JL; Corbella J
    Arch Toxicol; 1992; 66(3):188-92. PubMed ID: 1497482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole embryo culture, teratogenesis, and the estimation of teratologic risk.
    New DA
    Teratology; 1990 Dec; 42(6):635-42. PubMed ID: 2087684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicology in the drug discovery and development process.
    Dorato MA; Buckley LA
    Curr Protoc Pharmacol; 2006 Apr; Chapter 10():Unit10.3. PubMed ID: 22294168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.